-PD-1 TREATMENT OF LUNG CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND ANOTHER ANTI-CANCER AGENT

摘要

The disclosure provides a method of treating a subject suffering from lung cancer comprising administering to a subject suffering from lung cancer a therapeutically effective amount of (a) an antibody that specifically binds to a programmed death-1 (PD-1) receptor and inhibits PD- ; And (b) administering another anti-cancer agent. Other anti-cancer agents include platinum-based dual chemotherapy, EGFR-targeted tyrosine kinase inhibitors, bevacizumab, anti-cytotoxic T-lymphocyte antigen-4 (CTLA-4) antibodies, And may be any other therapy used to treat.